Current portfolio

New Amsterdam Pharma

New Amsterdam Pharma is developing lipid-lowering therapies for diseases with large unmet need.

Subscribe for the latest updates

Subscribe to EQT's press releases, regulatory press releases and updates.

Type of news
Preferred language

About

Teams

Responsibility

Investments

Shareholders

Media

Contact

Legal

EQT logo
A purpose-driven global investment organization
© EQT AB 2022. EQT AB (PUBL). REGISTRATED OFFICE IN STOCKHOLM, SWEDEN. REGISTRATION NUMBER: 556849-4180